logo

For the Inventor, By the Inventor

London, United Kingdom

Ark Therapeutics Limited


USPTO Granted Patents = 11

% Expired Patents = 81.8



Trademarks = 1

Forward Citations = 10

Loading Chart...
Loading Chart...

28 inventors (with patents filed for the assignee):

goldMedal John Martin (4 out of 9 patents)

silverMedal Seppo Yla-Herttuala (4 out of 9 patents)

bronzeMedal Stephen George Edward Barker (3 out of 11 patents)

4.  Hugh Edward Montgomery (2 out of 6 patents)

5.  Haiyan Jia (2 out of 3 patents)

6.  Ian Zachary (2 out of 4 patents)

7.  Jorge Daniel Erusalimsky (2 out of 6 patents)

8.  Kari Juhani Airenne (2 out of 4 patents)

9.  David Lawrence Selwood (2 out of 17 patents)

10.  Basil Hartzoulakis (1 out of 11 patents)

11.  Chris Chapman (1 out of 3 patents)

12.  Charles Henry Rodeck (1 out of 1 patent)

13.  Michelle Tickner (1 out of 2 patents)

14.  Lili Cheng (1 out of 2 patents)

15.  Katie Ellard (1 out of 2 patents)


11 patents:

1. 8334271 - Use of VEGF in the treatment of retarded fetal growth in pregnancy (2012-12-18),
2. 8227606 - Arginine derivatives with NP-1 antagonistic activity (2012-07-24),
3. 7905847 - Device for protecting wounds on limbs (2011-03-15),
4. 7393677 - Avidin-pseudotyped viral vectors and their use (2008-07-01),
5. 7320679 - Therapeutic use of growth factor, and delivery device, especially for the treatment of intimal hyperplasia (2008-01-22),
6. 7223835 - VEGF peptides and their use for inhibiting angiogenesis (2007-05-29),
7. 7208291 - Nucleic acids encoding biotin-binding receptors (2007-04-24),
8. 7071183 - Use of inhibitors of the renin-angiotensin system (2006-07-04),
9. 7022693 - Treatment of lipodystrophy (2006-04-04),
10. 6982358 - Protective cover for injured limbs (2006-01-03),
11. 6579855 - Adenovirus-mediated gene therapy (2003-06-17),
Company Overview
Ark Therapeutics Limited is a biotechnology company based in London, specializing in the development of innovative therapies for serious medical conditions. The organization focuses on advanced gene and cell therapies, particularly in the fields of oncology and regenerative medicine. By leveraging cutting-edge research and technology, Ark Therapeutics aims to address unmet medical needs and improve patient outcomes through its proprietary platforms and product candidates.
Profile summary synthesized from public USPTO records and patent filings.

logo

Company Badge

USPTO Data Jan 1 1976 - Oct 20 2026

11 Patents

#305 in London

#1,600 in United Kingdom

#51,801 in the World

London, GB
London, United Kingdom

Ark Therapeutics Limited

Forward Citations = 10

28 inventors:

goldMedal John Martin (4 out of 9 patents)

silverMedal Seppo Yla-Herttuala (4 out of 9 patents)

bronzeMedal Stephen George Edward Barker (3 out of 11 patents)

4.  Hugh Edward Montgomery (2 out of 6 patents)

5.  Haiyan Jia (2 out of 3 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Ark Therapeutics Limited. Retrieved from https://idiyas.com/company/ark-therapeutics

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…